“bcr-abl (b2a2)-derived peptide vaccine”的概念、定义、翻译、参考文献-科学参考

A peptide vaccine consisting of the bcr-abl b2a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b2a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b2a2 fusion protein. Fusion genes in CML typically result from the fusion of either BCR exon b2 or BCR exon b3 to ABL exon a2, a 'b3a2' or a 'b2a2' fusion.

单词	bcr-abl (b2a2)-derived peptide vaccine
释义	bcr-abl (b2a2)-derived peptide vaccine A peptide vaccine consisting of the bcr-abl b2a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b2a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b2a2 fusion protein. Fusion genes in CML typically result from the fusion of either BCR exon b2 or BCR exon b3 to ABL exon a2, a 'b3a2' or a 'b2a2' fusion.
随便看	germ German chamomile German Commission E germ cell germ cells germ cell tumor germfree germicide germination germline germline DNA germline mutation germline variant Gerota's capsule Gerota's fascia Gerson therapy gestational trophoblastic disease gestational trophoblastic tumor Gesterol 100 gFOBT GG745 ghrelin peptide analogue GI GI14721 GI-4000 vaccine